Skip to main content
SpringerLink
Log in

Should a Lower Treatment Line Be Used When Treating Paracetamol Poisoning in Patients with Chronic Alcoholism?

A Case Against

  • Current Opinion
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

The widespread practice of using a lower plasma paracetamol (acetaminophen) concentration threshold for the treatment of paracetamol poisoning in patients with chronic alcoholism has been introduced on the basis of anecdotal case reports.

In animals, acute alcohol loading inhibits toxic metabolic activation of paracetamol whilst chronic alcohol administration results in cytochrome P450 (CYP) 2E1 induction with increased toxic metabolic activation of paracetamol by CYP2E1 and increased hepatotoxicity. However, due to species differences in CYP expression, activity and induction, it is not possible extrapolate the results of these animal studies to clinical situations in humans. Isoenzymes are also responsible for the metabolic activation of paracetamol in humans and human studies to date have not convincingly demonstrated increased toxic metabolic activation of paracetamol in patients with chronic alcoholism. Acute alcohol ingestion at the time of a paracetamol overdose is probably protective and the timing and chronicity of alcohol intake is therefore crucial in the interpretation of the effects of alcohol on paracetamol overdose. One of the problems in the interpretation of the literature to date is that insufficient information is available on the timing of alcohol intake in relation to the ingestion of paracetamol.

Whilst it is possible that chronic exposure to excessive amounts of alcohol does predispose patients with paracetamol overdose to hepatotoxicity, a critical review of the literature reveals that the evidence to date does not support this. A prospective, controlled study is required. On the basis of the scientific evidence to date, use of the 100 line for patientswith chronic alcoholism, in countries where the 200 line represents the standard treatment line, is unjustified.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Hawton K, Townsend E, Deeks J, et al. Effects of legislation restricting pack sizes of paracetamol and salicylate on self-poisoning in the United Kingdom: before and after study. BMJ 2001 May 19; 322(7296): 1203–7

    Article  PubMed  CAS  Google Scholar 

  2. Brotodihardjo AE, Batey RG, Farrell GC, et al. Hepatotoxicity from paracetamol poisoning in western Sydney. Med J Aust 1992 Sep 21; 157(6): 382–5

    PubMed  CAS  Google Scholar 

  3. Gow PJ, Smallwood RA, Angus PW. Paracetamol overdose in a liver transplant centre: an 8-year experience. J Gastroenterol Hepatol 1999 Aug; 14(8): 817–21

    Article  PubMed  CAS  Google Scholar 

  4. Litovitz TL, Klein-Schwartz W, White S, et al. 2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2001 Sep; 19(5): 337–95

    Article  PubMed  CAS  Google Scholar 

  5. Management of acute paracetamol poisoning. Guidelines agreed by the UK National Poisons Information Service 1998. Supplied to accident and emergency centres in the United Kingdom by the Paracetamol Information Centre in collaboration with the British Association for Accident and Emergency Medicine. London; Paracetamol Information Centre, 1998

  6. Wright N, Prescott LF. Potentiation by previous drug therapy of hepatotoxicity following paracetamol overdosage. Scott Med J 1973; 18: 56–8

    CAS  Google Scholar 

  7. Scott CR, Stewart MJ. Cysteamine treatment in paracetamol overdose. Lancet 1975 Feb 22; I(7904): 452–3

    Article  Google Scholar 

  8. Emby DJ, Fraser BN. Hepatotoxicity of paracetamol enhanced by ingestion of alcohol. S Afr Med J 1977; 51: 208–9

    PubMed  CAS  Google Scholar 

  9. Johnson MW, Friedman PA, Mitch WE. Alcoholism, non-prescription drugs and hepatotoxicity: the risk from unknown acetaminophen ingestion. Am J Gastroenterol 1981 Dec; 76(6): 530–3

    PubMed  CAS  Google Scholar 

  10. Himmelstein DU, Woolhandler SJ, Adler RD. Elevated SGOT/SGPT ratio in alcoholic patients with acetaminophen hepatotoxicity. Am J Gastroenterol 1984 Sep; 79(9): 718–20

    PubMed  CAS  Google Scholar 

  11. Fleckenstein JL. Nyquil and acute hepatic necrosis [letter]. N Engl J Med 1985 Jul 4; 313(1): 48

    PubMed  CAS  Google Scholar 

  12. Yasunaga M, Matsuda S, Murata M, et al. Two cases of acute liver injury caused by ingesting small doses of acetaminophen. Acta Hepatologica Japonica 1985; 26: 493–9

    Article  Google Scholar 

  13. Bell H, Schjonsby H, Raknerud N. Severe liver damage following suicidal intake of paracetamol [in Norwegian]. Tidsskr Nor Laegeforen 1987 Apr 20; 107: 1041–2

    PubMed  CAS  Google Scholar 

  14. Denison H, Kaczynski J, Wallerstedt S. Paracetamol medication and alcohol abuse: a dangerous combination for the liver and kidney. Scand J Gastroenterol 1987 Aug; 22(6): 701–4

    Article  PubMed  CAS  Google Scholar 

  15. McClain CJ, Holtzman JL, Allen J, et al. Clinical features of acetaminophen toxicity. J Clin Gastroenterol 1988 Feb; 10(1): 76–80

    Article  PubMed  CAS  Google Scholar 

  16. Foust RT, Reddy KR, Jeffers LJ, et al. Nyquil-associated liver injury. Am J Gastroenterol 1989 Apr; 84(4): 422–5

    PubMed  CAS  Google Scholar 

  17. Shimizu M, Tokita H, Koshino Y, et al. An autopsy case of acute hepatic failure caused by ingesting a small dose of acetaminophen in a drinker. Acta Hepatologica Japonica 1989; 30: 690–4

    Article  Google Scholar 

  18. McClements BM, Hyland M, Callender ME, et al. Management of paracetamol poisoning complicated by enzyme induction due to alcohol or drugs [letter]. Lancet 1990 Jun 23; 335(8704): 1526

    Article  PubMed  CAS  Google Scholar 

  19. Mrvos R, Schneider SM, Dean BS, et al. Orthotopic liver transplants necessitated by acetaminophen-induced hepatotoxicity. Vet Hum Toxicol 1992 Oct; 34(5): 425–7

    PubMed  CAS  Google Scholar 

  20. Cheung L, Potts RG, Meyer KC. Acetaminophen treatment nomogram. N Engl J Med 1994 Jun 30; 330(26): 1907–8

    Article  PubMed  CAS  Google Scholar 

  21. Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994 Dec 21; 272(23): 1845–50

    Article  PubMed  CAS  Google Scholar 

  22. Schiødt FV, Rochlling FA, Casey DL, et al. Acetaminophen toxicity in an urban county hospital. N Engl J Med 1997 Oct 16; 337(16): 1112–7

    Article  PubMed  Google Scholar 

  23. Artnak KE, Wilkinson SS. Fulminant hepatic failure in acute acetaminophen overdose. Dimens Crit Care Nurs 1998 May-Jun; 17(3): 135–44

    Article  PubMed  CAS  Google Scholar 

  24. Bridger S, Henderson K, Glucksman E, et al. Deaths from low dose paracetamol poisoning. BMJ 1998 Jun 6; 316(7146): 1724–5

    Article  PubMed  CAS  Google Scholar 

  25. Prescott LF, Illingworth RN, Critchley JAJH, et al. Intravenous N-acetylcyteine: the treatment of choice for paracetamol poisoning. BMJ 1979 Nov 3; 2(6198): 1097–100

    Article  PubMed  CAS  Google Scholar 

  26. Bailey B, McGuigan MA. Management of anaphylactoid reactions to N-acetylcysteine. Ann Emerg Med 1998 Jun; 31(6): 710–5

    Article  PubMed  CAS  Google Scholar 

  27. Dawson AH, Henry DA, McEwen J. Adverse reaction to N-acetylcysteine during treatment for paracetamol poisoning. Med J Aust 1989 Mar 20; 150(6): 329–31

    PubMed  CAS  Google Scholar 

  28. Mant TG, Tempowski JH, Volans GN, et al. Adverse reactions to acetylcysteine and effects of overdose. BMJ (Clin Res Ed) 1984 Jul 28; 289(6439): 217–9

    Article  CAS  Google Scholar 

  29. Herskovitz E, Shorer Z, Levitas A, et al. Status epilepticus following intravenous N-acetylcysteine therapy. Isr J Med Sci 1996; 32: 1102–4

    Google Scholar 

  30. Death after N-acetylcysteine [editorial]. Lancet 1984; I: 1421

    Google Scholar 

  31. Jones AL, Jarvie DR, Simpson D, et al. Pharmacokinetics of N-acetylcysteine are altered in patients with chronic liver disease. Aliment Pharmacol Ther 1997 Aug; 11(4): 787–91

    Article  PubMed  CAS  Google Scholar 

  32. Jones AL, Bangash IH, Bouchier IA, et al. Portal and systemic haemodynamic action of N-acetylcysteine in patients with stable cirrhosis. Gut 1994 Sep; 35(9): 1290–3

    Article  PubMed  CAS  Google Scholar 

  33. Jones AL, Haynes W, MacGilchrist AJ, et al. N-acetylcysteine acts as a potent peripheral vasodilator [abstract]. British Society of Gastroenterology 1994. Gut 1994; 35(S10): W40

    Google Scholar 

  34. Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics 1975 Jun; 55(6): 871–6

    PubMed  CAS  Google Scholar 

  35. Smilkstein MJ, Bronstein AC, Linden C, et al. Acetaminophen overdose: a 48 hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med 1991 Oct; 20(10): 1058–63

    Article  PubMed  CAS  Google Scholar 

  36. Barnes J, Abban M, Howarth P. Deaths from low dose paracetamol poisoning. Executive action is needed to change national guideline [letter]. BMJ 1998 Dec 12; 317(7173): 1054

    Article  Google Scholar 

  37. Cameron MG. Lower threshold has not yet overburdened hospital services in Gloucester [letter]. BMJ 1998 Dec 12; 317(7173): 1055

    Google Scholar 

  38. Routledge P, Vale JA, Bateman DN, et al. Paracetamol (acetaminophen) poisoning; No need to change current guidelines to accident departments [editorial]. BMJ 1998 Dec 12; 317(7173): 1609–10

    Article  PubMed  CAS  Google Scholar 

  39. Clemmesen JO, Ott P, Dalhoff KP, et al. Recommendations for treatment of paracetamol poisoning. Danish Medical Society, Study of Liver [in Danish]. Ugeskr Laeger 1996 Nov 25; 158(48): 6892–5

    PubMed  CAS  Google Scholar 

  40. Jones AL. Recent advances in the management of late paracetamol poisoning. Emerg Med 2000; 12: 14–21

    Article  Google Scholar 

  41. Smilkstein MJ, Douglas DR, Daya MR. Acetaminophen poisoning and liver function. N Engl J Med 1994 Nov 10; 331(19): 1310–1

    Article  PubMed  CAS  Google Scholar 

  42. Miner DJ, Kissinger PT. Evidence for the involvement of N-acetyl-p-benzoquinoneimine in acetaminophen metabolism. Biochem Pharmacol 1979 Nov 15; 28(22): 3285–90

    Article  PubMed  CAS  Google Scholar 

  43. Mitchell JR, Jollow DJ, Potter WZ, et al. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther 1973 Oct; 187(1): 185–94

    PubMed  CAS  Google Scholar 

  44. Sato C, Matsuda Y, Lieber CS. Increased hepatotoxicity of acetaminophen after chronic ethanol consumption in the rat. Gastroenterology 1981 Jan; 80(1): 140–8

    PubMed  CAS  Google Scholar 

  45. Walker RM, McElligott TF, Power EM, et al. Increased acetaminophen-induced hepatotoxicity after chronic ethanol consumption in mice. Toxicology 1983; 28(3): 193–206

    Article  PubMed  CAS  Google Scholar 

  46. Altomare E, Leo MA, Lieber CS. Interaction of acute ethanol administration with acetaminophen metabolism and toxicity in rats fed alcohol chronically. Alcohol Clin Exp Res 1984 Jul-Aug; 8(4): 405–8

    Article  PubMed  CAS  Google Scholar 

  47. Altomare E, Leo MA, Sato C, et al. Interaction of ethanol with acetaminophen metabolism in the baboon. Biocem Pharmacol 1984 Jul 15; 33(14): 2207–12

    Article  CAS  Google Scholar 

  48. Tredger JM, Smith HM, Read RB, et al. Effects of ethanol ingestion on the hepatotoxicity and metabolism of paracetamol in mice. Toxicology 1985 Sep; 36(4): 341–52

    Article  PubMed  CAS  Google Scholar 

  49. Tredger JM, Smith HM, Read RB, et al. Effects of ethanol ingestion on the metabolism of a hepatotoxic dose of paracetamol in mice. Xenobiotica 1986 Jul; 16(7): 661–70

    Article  PubMed  CAS  Google Scholar 

  50. Perrot N, Nalpas B, Yang CS, et al. Modulation of cytochrome P450 isoenzymes in human liver, by ethanol and drug intake. Eur J Clin Invest 1989 Dec; 19(6): 549–55

    Article  PubMed  CAS  Google Scholar 

  51. Lucas D, Ménez C, Girre C, et al. Decrease in cytochrome P4502E1 as assessed by the rate of chlozoxazone hydroxylation in alcoholics during the withdrawal phase. Alcohol Clin Exp Res 1995 Apr; 19(2): 362–6

    Article  PubMed  CAS  Google Scholar 

  52. Chien JY, Thummel KE, Slattery JT, et al. Ethanol increases risk of acetaminophen hepatotoxicity in adults [abstract]. Hepatology 1998; 28: 257A

    Google Scholar 

  53. Tredger JM, Thuluvath P, Williams R, et al. Metabolic basis for high paracetamol dosage without hepatic injury: a case study. Hum Exp Toxicol 1995 Jan; 14(1): 8–12

    Article  PubMed  CAS  Google Scholar 

  54. Chern I, Brent J, Slattery J, et al. Is it safe to give acetaminophen to alcoholics? A metabolic study [abstract]. Vet Hum Toxicol 1993; 35: 365

    Google Scholar 

  55. Ueshima Y, Tsutsumi M, Takase S, et al. Acetaminophen metabolism in patients with different cytochrome P-4502E1 genotypes. Alcohol Clin Exp Res 1996; 20: A25–8

    Article  Google Scholar 

  56. Niemela O, Parkkila S, Juvonen R, et al. Cytochromes P450 2A6, 2E1 and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases. J Hepatol 2000; 33: 893–901

    Article  PubMed  CAS  Google Scholar 

  57. Patten CJ, Thomas PE, Guy RE, et al. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol 1993 Jul-Aug; 6(4): 511–8

    Article  PubMed  CAS  Google Scholar 

  58. Chen W, Koenigs LL, Thompson SJ, et al. Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechl metabolited by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6. Chem Res Toxicol 1998; 11: 295–301

    Article  PubMed  CAS  Google Scholar 

  59. Thomas SH, Horner JE, Chew K, et al. Presentation of poisoned patients to accident and emergency departments in the North of England. Hum Exp Toxicol 1996 Jun; 15(6): 466–70

    Article  PubMed  CAS  Google Scholar 

  60. Prescott LF. Paracetamol overdosage: pharmacological considerations and clinical management. Drugs 1983 Mar; 25(3): 290–314

    Article  PubMed  CAS  Google Scholar 

  61. Kuffner E, Dart RC, Bogdan GM. Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 2001 Oct 8; 161(18): 2247–52

    Article  PubMed  CAS  Google Scholar 

  62. Daly F, Dart RC, Bogdan GM, et al. Repeated supratherapeutic dosing of acetaminophen (apap): can serumtransaminase levels predict the risk of hepatotoxicity? J Toxicol Clin Toxicol 2000; 38: 580–1

    Google Scholar 

  63. Kenny JF, Pollack M, Rothman R, et al. Routine screening for acetaminophen (APAP) toxicity of patients requesting alcohol detoxification. J Stud Alcohol 1999 Jan; 60(1): 139–40

    PubMed  CAS  Google Scholar 

  64. Villeneuve J-P, Raymond G, Bruneau J, et al. Pharmacokinetics amd metabolism of acetamnophen in normal, alcoholic amd cirrhotic subjects [in French]. Gastroenterol Clin Biol 1983 Nov; 7(11): 898–902

    PubMed  CAS  Google Scholar 

  65. Prescott LF, Critchley JAJH. Drug interactions affecting analgesic toxicity. Am J Med 1983 Nov 14; 75(5A): 113–6

    Article  PubMed  CAS  Google Scholar 

  66. Skinner MH, Matano R, Hazle W, et al. Acetaminophen metabolism in recovering alcoholics. Methods Find Exp Clin Pharmacol 1990 Sep; 12(7): 513–5

    PubMed  CAS  Google Scholar 

  67. Bray GP, Mowat C, Muir DF, et al. The effect of chronic alcohol intake on prognosis and outcome in paracetamol overdose. Hum Exp Toxicol 1991 Nov; 10(6): 435–8

    Article  PubMed  CAS  Google Scholar 

  68. Read RB, Tredger JM, Williams R. Analysis of factors responsible for continuing mortality after paracetamol overdose. Hum Toxicol 1986 May; 5 (3): 201–6

    Google Scholar 

  69. Makin AJ, Wendon J, Williams R. A seven year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology 1995 Dec; 109(6): 1907–16

    Article  PubMed  CAS  Google Scholar 

  70. Rumack BH, Peterson RG, Koch GC, et al. Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med 1981 Feb; 141(3): 380–5

    Article  PubMed  CAS  Google Scholar 

  71. Smilkstein MJ, Knapp GL, Kulig KW, et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: analysis of the national multicenter study 1976-1985. N Engl J Med 1988 Dec; 319(24): 1557–62

    Article  PubMed  CAS  Google Scholar 

  72. Makin A, Williams R. Paracetamol hepatotoxicity and alcohol consumption in deliberate and accidental overdose. Q J Med 2000 Jun; 93(6): 341–9

    Article  CAS  Google Scholar 

  73. Bradley MP, Nguyen-Van-Tam JS, et al. ‘Late presenter’ after paracetamol self-poisoning. J Epidemiol Community Health 1998 Nov; 52(11): 762–3

    Article  PubMed  CAS  Google Scholar 

  74. Price VF, Miller MG, Jollow DJ. Mechanisms of fasting-induced potentiation of acetaminophen hepatotoxicity in the rat. Biochem Pharmacol 1987 Feb 15; 36(4): 427–33

    Article  PubMed  CAS  Google Scholar 

  75. Lauterburg BH, Davies S, Mitchell JR. Ethanol suppresses hepatic glutathione synthesis in rats in vivo. J Pharmacol Exp Ther 1984 Jul; 230(1): 7–11

    PubMed  CAS  Google Scholar 

  76. Thummel KE, Slattery JT, Nelson SD, et al. Effect of ethanol on hepatotoxicity of acetaminophen in mice and on reactive metabolite formation by mouse and human liver microsomes. Toxicol Appl Pharmacol 1989 Sep 15; 100(3): 391–7

    Article  PubMed  CAS  Google Scholar 

  77. Serrar D, Thevenin M. Toxicité du paracétamol chez la souris Swiss traitée par l’alcool éthylique en aigu ou à court terme. Revue l’Alcoolisme 1987; 32: 105–11

    CAS  Google Scholar 

  78. Wong LT, Whitehouse LW, Solomonraj G, et al. Effect of a concomitant single dose of ethanol on the hepatotoxicity in mice. Toxicology 1980; 17(3): 297–309

    Article  PubMed  CAS  Google Scholar 

  79. Sato C, Lieber CS. Mechanism of the preventive effect of ethanol on acetaminophen-induced hepatotoxicity. J Pharmacol Exp Ther 1981 Sep; 218(3): 811–5

    PubMed  CAS  Google Scholar 

  80. Banda PW, Quart BD. The effect of alcohol on the toxicity of acetaminophen in mice. Res Commun Chem Pathol Pharmacol 1984 Jan; 43(1): 127–38

    PubMed  CAS  Google Scholar 

  81. Lee S-M, Cho T-S, Cha Y-N. Ethanol protects from acetaminophen inducible hepatic necrosis by inhibiting its metabolic activation in mice. Korean J Physiol Pharmacol 1998; 2: 261–9

    CAS  Google Scholar 

  82. Sato C, Nakano M, Lieber CS. Prevention of acetaminophen-induced hepatotoxicity by acute ethanol administration in the rat: comparison with carbon tetrachloride-induced hepatotoxicity. J Pharmacol Exp Ther 1981 Sep; 218(3): 805–10

    PubMed  CAS  Google Scholar 

  83. Thummel KE, Slattery JT, Nelson SD. Mechanism by which ethanol diminishes the hepatotoxicity of acetaminophen. J Pharmacol Exp Ther 1988 Apr; 245(1): 129–36

    PubMed  CAS  Google Scholar 

  84. Sato C, Liu J, Miyakawa H, et al. Inhibition of acetaminophen activation by ethanol and acetaldehyde in liver microsomes. Life Sci 1991; 49(24): 1787–91

    Article  PubMed  CAS  Google Scholar 

  85. Prescott LF. Paracetamol, alcohol and the liver. Br J Clin Pharmacol 2000 Apr; 49(4): 291–301

    Article  PubMed  CAS  Google Scholar 

  86. Banda PW, Quart BD. The effect of mild alcohol consumption on the metabolism of acetaminophen in man. Res Commun Chem Pathol Pharmacol 1982 Oct; 38(1): 57–70

    PubMed  CAS  Google Scholar 

  87. Altomare E, Vendemiale G, Trizio T, et al. Does acute ethanol really protect against acetaminophen hepatotoxicity? Am J Gastroenterol 1986 Jan; 81(1): 91–3

    PubMed  CAS  Google Scholar 

  88. Critchley JA, Dyson EH, Scott AW, et al. Is there a place for cimetidine or ethanol in the treatment of paracetamol poisoning? Lancet 1983 Jun 18; I(8338): 1375–6

    Article  Google Scholar 

  89. Rumack BH. Acetaminophen overdose. Am J Med 1983 Nov 14; 75(5A): 104–12

    Article  PubMed  CAS  Google Scholar 

  90. Rumack BH. Acetaminophen overdose in young children: treatment and effects of alcohol and other additional ingestants in 417 cases. Am J Dis Child 1984 May; 138(5): 428–33

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No specific funding was received to assist in the preparation of this manuscript.

Paul Dargan and Alison Jones have acted as scientific advisors and received funding from GlaxoSmithKline to attend scientific meetings.

Author information

Authors and Affiliations

  1. National Poisons Information Service, Guy’s and St Thomas’ NHS Trust, Avonley Road, London, SE14 5ER, United Kingdom

    Paul I. Dargan &  Alison L. Jones

Authors
  1. Paul I. Dargan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alison L. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alison L. Jones.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dargan, P.I., Jones, A.L. Should a Lower Treatment Line Be Used When Treating Paracetamol Poisoning in Patients with Chronic Alcoholism?. Drug-Safety 25, 625–632 (2002). https://doi.org/10.2165/00002018-200225090-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200225090-00002

Keywords

Search

Navigation